InterCure Ltd. (INCR)
InterCure Ltd. Statistics
Share Statistics
InterCure Ltd. has 47.16M shares outstanding. The number of shares has increased by 0.42% in one year.
Shares Outstanding | 47.16M |
Shares Change (YoY) | 0.42% |
Shares Change (QoQ) | 0.42% |
Owned by Institutions (%) | 5.54% |
Shares Floating | 26.54M |
Failed to Deliver (FTD) Shares | 750 |
FTD / Avg. Volume | 2.28% |
Short Selling Information
The latest short interest is 43.1K, so 0.09% of the outstanding shares have been sold short.
Short Interest | 43.1K |
Short % of Shares Out | 0.09% |
Short % of Float | 0.17% |
Short Ratio (days to cover) | 0.84 |
Valuation Ratios
The PE ratio is -3.6 and the forward PE ratio is -1.14. InterCure Ltd.'s PEG ratio is 0.02.
PE Ratio | -3.6 |
Forward PE | -1.14 |
PS Ratio | 0.63 |
Forward PS | 0.1 |
PB Ratio | 0.49 |
P/FCF Ratio | -3.97 |
PEG Ratio | 0.02 |
Enterprise Valuation
InterCure Ltd. has an Enterprise Value (EV) of 302.9M.
EV / Earnings | -4.89 |
EV / Sales | 0.85 |
EV / EBITDA | -12.67 |
EV / EBIT | -7.29 |
EV / FCF | -5.38 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.43.
Current Ratio | 1.85 |
Quick Ratio | 1.38 |
Debt / Equity | 0.43 |
Total Debt / Capitalization | 30.07 |
Cash Flow / Debt | -0.27 |
Interest Coverage | -1.72 |
Financial Efficiency
Return on equity (ROE) is -0.14% and return on capital (ROIC) is -6.6%.
Return on Equity (ROE) | -0.14% |
Return on Assets (ROA) | -0.08% |
Return on Capital (ROIC) | -6.6% |
Revenue Per Employee | $1,316,862.96 |
Profits Per Employee | $-229,477.78 |
Employee Count | 270 |
Asset Turnover | 0.45 |
Inventory Turnover | 2.36 |
Taxes
Income Tax | 2.25M |
Effective Tax Rate | -0.04 |
Stock Price Statistics
The stock price has increased by -18.18% in the last 52 weeks. The beta is 0.1, so InterCure Ltd.'s price volatility has been higher than the market average.
Beta | 0.1 |
52-Week Price Change | -18.18% |
50-Day Moving Average | 1.64 |
200-Day Moving Average | 1.94 |
Relative Strength Index (RSI) | 48.29 |
Average Volume (20 Days) | 32.94K |
Income Statement
In the last 12 months, InterCure Ltd. had revenue of 355.55M and earned -61.96M in profits. Earnings per share was -1.36.
Revenue | 355.55M |
Gross Profit | 105.09M |
Operating Income | -41.57M |
Net Income | -61.96M |
EBITDA | -23.9M |
EBIT | -41.57M |
Earnings Per Share (EPS) | -1.36 |
Balance Sheet
The company has 101.14M in cash and 195.68M in debt, giving a net cash position of -94.54M.
Cash & Cash Equivalents | 101.14M |
Total Debt | 195.68M |
Net Cash | -94.54M |
Retained Earnings | -204M |
Total Assets | 740.89M |
Working Capital | 161.94M |
Cash Flow
In the last 12 months, operating cash flow was -53.63M and capital expenditures -2.62M, giving a free cash flow of -56.25M.
Operating Cash Flow | -53.63M |
Capital Expenditures | -2.62M |
Free Cash Flow | -56.25M |
FCF Per Share | -1.23 |
Margins
Gross margin is 29.56%, with operating and profit margins of -11.69% and -17.43%.
Gross Margin | 29.56% |
Operating Margin | -11.69% |
Pretax Margin | -17.24% |
Profit Margin | -17.43% |
EBITDA Margin | -6.72% |
EBIT Margin | -11.69% |
FCF Margin | -15.82% |
Dividends & Yields
INCR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -83.95% |
FCF Yield | -73.62% |
Analyst Forecast
Currently there are no analyst rating for INCR.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Apr 8, 2021. It was a backward split with a ratio of 1:4.
Last Split Date | Apr 8, 2021 |
Split Type | backward |
Split Ratio | 1:4 |
Scores
Altman Z-Score | 0.39 |
Piotroski F-Score | 3 |